Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Description

List of Tables

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

The global market for pharmaceutical drugs and biologics for chronic disease management is projected to grow from $513.5 billion in 2024 to $754.0 billion by 2029, at a CAGR of 8.0% from 2024 through 2029.

The global market for digital therapeutics for chronic disease management is projected to grow from $64.6 billion in 2024 to $111.7 billion by 2029, at a CAGR of 11.6% from 2024 through 2029.

Report Scope

Chronic disease management encompasses drugs and medical device-based techniques. This report can serve as an analytical business tool to evaluate the global market for therapeutics and advanced device technologies for chronic disease management.

This report analyzes market trends with data from 2023, estimates for 2024 and projections of CAGRs through 2029. It evaluates the market potential for chronic disease management and provides an analysis of the competitive landscape. The report covers the market's drivers, restraints and opportunities, as well as the market shares of leading companies.

The market is segmented into product type, application, end user, and geographic region. Product segments include pharmaceuticals and biologics (drugs and biologics), medical devices (traditional and wearable devices) and digital therapeutics. Application areas (disease categories) are cancer, metabolic disorders, musculoskeletal disorders, cardiovascular conditions, immunological disorders, gastrointestinal disorders, respiratory diseases, neurological conditions, psychiatric conditions, and others. End users are categorized into hospitals and other facilities and home care. The global market is segmented into the regions of North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This analysis also includes broken down by country.

Report Includes

106 data tables and 39 additional tables
Analyses of global market trends, with historic market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
Estimates of the current market size and revenue prospects of the global market, along with a market share analysis by product type, application, end user, and region
Analysis of the market dynamics, technological advances, regulations, and the macroeconomic factors influencing the market
A look into the current state of chronic diseases and disorders, with an emphasis on advance needle-free drug delivery technologies, diagnostic methods, and smart device technologies that support chronic disease management
Identification of promising new drugs, biologics, and emerging device technologies still in the development and testing stages
A look at the regulatory structure for pharmaceuticals and medical devices, pricing and reimbursement structure, marketed and pipeline products and their potential for commercialization
A look at the recent patent grants
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and a venture funding outlook
Profiles of market leaders, including Abbott, Bristol Myers Squibb Co., F. Hoffmann-La Roche Ltd., Pfizer Inc., and Johnson & Johnson Services Inc.

Product Code: HLC239C

Chapter 1 Executive Summary

Market Outlook
Scope of Report
What's New in This Update?
Market Summary

Chapter 2 Market Overview

Market Insights
Regulatory Background
Chronic Disease Management Act of 2021 (CDMA)
Regional Regulatory Frameworks for Chronic Disease Medical Devices
Regulatory Systems for Pharmaceuticals, by Region
Pricing and Reimbursement Background
Pricing and Reimbursement for Medical Devices, by Region
Pricing and Reimbursement for Pharmaceuticals, by Region

Chapter 3 Market Dynamics

Overview
Market Drivers
Growing Aging Population Worldwide
Growing Prevalence of Chronic Diseases
Technological Advances
Government Initiatives and Funding
Market Restraints
High Cost of Treatments
Patent Expiry and Shorter Product Life Cycles
Regulatory Issues for Drugs, Medical Devices and Software Applications
Limited Access in Low-Income Regions
Market Challenges
Medication Nonadherence
Regulatory Challenges
Challenges with Digital Health Applications
Market Opportunities
Digital Therapeutics
Strong Research and Development Initiatives from Key Market Players

Chapter 4 Market Segmentation Analysis

Segmentation Breakdown
Market Analysis, by Product Type
Pharmaceutical Drugs and Biologics
Medical Devices
Digital Therapeutics
Market Analysis, by Application
Oncological Diseases
Metabolic Disorders
Cardiovascular Diseases
Immunological Disorders
Respiratory Diseases
Musculoskeletal Disorders
Chronic Gastrointestinal Diseases
Neurological Diseases
Psychiatric Disorders
Other Applications
Market Analysis, by End User
Home Care
Hospitals and Others
Geographic Breakdown
Market Analysis, by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 5 Emerging Trends and Technologies

Overview
Mobile Health Technology
AI, Machine Learning, and Deep Learning in Chronic Care Management
Remote Patient Monitoring Devices
Digital Therapeutics
Biowearable Technology
Glucose-Sensing Contact Lenses
Recent Approvals and Launches of Novel Drug and Device Products

Chapter 6 ESG Developments

ESG in the Chronic Disease Management Industry
ESG Risk Ratings
BCC Research Viewpoint

Chapter 7 Competitive Landscape

Mergers, Acquisitions and Collaborations
Patent Analysis
Patent Review, by Assignee Country
Patent Review, by Year
Company Share Analysis
Strategic Alliances

Chapter 8 Appendix

Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
AMGEN INC.
ASTRAZENECA
BOSTON SCIENTIFIC CORP.
BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.
GSK PLC.
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC
PFIZER INC.

Product Code: HLC239C

List of Tables

Summary Table : Global Market for Chronic Disease Management, Therapeutics and Device Technologies, by Product Type, Through 2029
Table 1 : People 65 Years and Over, by Development Group, 2023 and 2050
Table 2 : People 65 Years or Over, by WHO Region, 2019 and 2050
Table 3 : Projected Number of U.S. Adults 50 and Older with More than One Chronic Condition
Table 4 : Recent EU-Level Initiatives Addressing Chronic Diseases, 2022
Table 5 : Weighted Adherence Rates in India, 2022
Table 6 : Global Market for Therapeutics and Device Technologies for Chronic Disease Management, by Product Type, Through 2029
Table 7 : Global Market for Pharmaceutical Drugs and Biologics for Chronic Disease Management, by Region, Through 2029
Table 8 : Global Market for Pharmaceutical Drugs and Biologics for Chronic Diseases Management, by Product, Through 2029
Table 9 : Recently Approved Pharmaceutical Drugs for Chronic Disease Management, 2024
Table 10 : Global Market for Pharmaceutical Drugs in Chronic Disease Management, by Region, Through 2029
Table 11 : Recently Approved Biologics for Chronic Disease Management, 2024
Table 12 : Global Market for Biologics in Chronic Disease Management, by Region, Through 2029
Table 13 : Global Market for Medical Devices for Chronic Disease Management, by Region, Through 2029
Table 14 : Global Market for Medical Devices for Chronic Disease Management, by Product Type, Through 2029
Table 15 : Global Market for Traditional Medical Devices for Chronic Disease Management, by Region, Through 2029
Table 16 : Global Market for Wearable Medical Devices for Chronic Disease Management, by Region, Through 2029
Table 17 : Global Market for Digital Therapeutics for Chronic Disease Management, by Region, Through 2029
Table 18 : Global Market for Therapeutics and Device Technologies for Chronic Disease Management, by Application, Through 2029
Table 19 : Cancer Deaths in the U.S., 2024
Table 20 : Global Market for Oncology Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 21 : Global Market for Metabolic Disorder Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 22 : Global Market for Cardiovascular Disease Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 23 : Global Market for Immunological Disorder Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 24 : Global Market for Respiratory Disease Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 25 : Global and Regional Key Findings on Rehabilitation Needs, 2021
Table 26 : Global Market for Musculoskeletal Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 27 : Global Market for GI Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 28 : Global Market for Neurological Disorder Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 29 : Global Market for Psychiatric Diseases Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 30 : Global Market for Other Disease Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 31 : Global Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 32 : Global Market for Home Care Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 33 : Global Market for Therapeutics and Device Technologies in Hospitals and Other Facilities in Chronic Disease Management, by Region, Through 2029
Table 34 : Global Market for Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029
Table 35 : North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 36 : North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 37 : North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 38 : North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by Country, Through 2029
Table 39 : U.S. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 40 : U.S. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 41 : U.S. Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 42 : Canada Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 43 : Canada Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 44 : Canadian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 45 : Mexican Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 46 : Mexican Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 47 : Mexican Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 48 : European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 49 : European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 50 : European Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 51 : European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Country, Through 2029
Table 52 : U.K. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 53 : U.K. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 54 : U.K. Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 55 : French Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 56 : French Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 57 : French Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 58 : Italian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 59 : Italian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 60 : Italian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 61 : Leading Causes of Disease Burden in Germany, by DALYs (Level 3), 2022
Table 62 : German Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 63 : German Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 64 : German Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 65 : Spanish Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 66 : Spanish Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 67 : Spanish Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 68 : Rest of European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 69 : Rest of European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 70 : Rest of European Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 71 : Percentage of Healthcare Professionals who Use Digital Health Technology or Mobile Health Apps, by Country, 2021
Table 72 : Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 73 : Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 74 : Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 75 : Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Country, Through 2029
Table 76 : Chinese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 77 : Chinese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 78 : Chinese Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 79 : Indian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 80 : Indian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 81 : Indian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 82 : Japanese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 83 : Japanese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 84 : Japanese Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 85 : Australian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 86 : Australian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 87 : Australian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 88 : South Korean Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 89 : South Korean Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 90 : South Korean Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 91 : Rest of Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029
Table 92 : Rest of Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 93 : Rest of Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 94 : RoW Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product Through 2029
Table 95 : RoW Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029
Table 96 : RoW Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029
Table 97 : AI-driven Drug Discovery and Development in Cardiology
Table 98 : ESG Highlights, by Leading Companies, 2023
Table 99 : ESG Risk Ratings for Pharma Firms in the Chronic Disease Management Market, 2023
Table 100 : M&A in the Chronic Disease Management Industry, 2021-2024
Table 101 : Patent Analysis, by Year, 2021-August 2024
Table 102 : Strategic Alliances in the Chronic Disease Management, Therapeutics and Device Technologies Market, 2021-2024
Table 103 : Information Sources in This Report
Table 104 : Abbreviations Used in This Report
Table 105 : Abbott: Company Snapshot
Table 106 : Abbott: Financial Performance, FY 2022 and 2023
Table 107 : Abbott: Product Portfolio
Table 108 : Abbott: News/Key Developments, 2023 and 2024
Table 109 : Amgen Inc.: Company Snapshot
Table 110 : Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 111 : Amgen Inc.: Product Portfolio
Table 112 : Amgen Inc.: News/Key Developments, 2021-2024
Table 113 : AstraZeneca: Company Snapshot
Table 114 : AstraZeneca: Financial Performance, FY 2022 and 2023
Table 115 : AstraZeneca: Product Portfolio
Table 116 : AstraZeneca: News/Key Developments, 2021-2024
Table 117 : Boston Scientific Corp.: Company Snapshot
Table 118 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 119 : Boston Scientific Corp.: Products Portfolio
Table 120 : Boston Scientific Corp.: News/Key Developments, 2023 and 2024
Table 121 : Bristol-Myers Squibb Co.: Company Snapshot
Table 122 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 123 : Bristol-Myers Squibb Co.: Product Portfolio
Table 124 : Bristol-Myers Squibb Co.: News/Key Developments, 2021-2024
Table 125 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 126 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 127 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 128 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021-2024
Table 129 : GSK Plc.: Company Snapshot
Table 130 : GSK Plc.: Financial Performance, FY 2022 and 2023
Table 131 : GSK Plc.: Product Portfolio
Table 132 : GSK Plc.: News/Key Developments, 2024
Table 133 : Johnson & Johnson Services Inc.: Company Snapshot
Table 134 : Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
Table 135 : Johnson & Johnson Services Inc.: Product Portfolio
Table 136 : Johnson & Johnson Services Inc.: News/Key Developments, 2022-2024
Table 137 : Medtronic: Company Snapshot
Table 138 : Medtronic: Financial Performance, FY 2022 and 2023
Table 139 : Medtronic: Product Portfolio
Table 140 : Medtronic: News/Key Developments, 2022-2024
Table 141 : Pfizer Inc.: Company Snapshot
Table 142 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 143 : Pfizer Inc.: Product Portfolio
Table 144 : Pfizer Inc.: News/Key Developments, 2022-2024

List of Figures

Summary Figure : Global Market for Chronic Disease Management, Therapeutics and Device Technologies, by Product Type, 2021-2029
Figure 1 : Use of Digital Technologies and Data in Patients' Medicines
Figure 2 : Comparison of Drug Approval Processes in the U.S. and EU
Figure 3 : Market Dynamics for Therapeutics and Devices for Chronic Disease Management
Figure 4 : Share of New Global Cases of Cancer, by Region, 2022
Figure 5 : Share of Global Cancer Mortality Cases, by Region, 2022
Figure 6 : Frequency of Non-adherence Behaviors, 2020
Figure 7 : Global Market Share of Therapeutics and Device Technologies for Chronic Disease Management, by Product Type, 2023
Figure 8 : Global Market Share of Therapeutics and Device Technologies in Chronic Disease Management, by End User, 2023
Figure 9 : Global Market for Therapeutics and Device Technologies in Chronic Disease Management, by Region, 2021-2029
Figure 10 : Global Market Share of Therapeutics and Device Technologies in Chronic Disease Management, by Region, 2023
Figure 11 : Role of AI in Anti-Cancer Drug Development
Figure 12 : 2024 Progress Assessment: Tracking Sustainable Development Goals
Figure 13 : Share of Patents Published on Chronic Disease Management, by Assignee Country, 2021-2024
Figure 14 : Global Market Shares of Chronic Disease Management, Therapeutics and Device Technologies, by Leading Companies, 2023
Figure 15 : Abbott: Revenue Share, by Country/Region, FY 2023
Figure 16 : Abbott: Revenue Share, by Business Unit, FY 2023
Figure 17 : Amgen Inc.: Revenue Share, by Country/Region, FY 2023
Figure 18 : Amgen Inc.: Revenue Share, by Business Unit, FY 2023
Figure 19 : AstraZeneca: Revenue Share, by Country/Region, FY 2023
Figure 20 : AstraZeneca: Revenue Share, by Business Unit, FY 2023
Figure 21 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
Figure 22 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
Figure 23 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
Figure 24 : Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023
Figure 25 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 27 : GSK Plc.: Revenue Share, by Country/Region, FY 2023
Figure 28 : GSK Plc.: Revenue Share, by Business Unit, FY 2023
Figure 29 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
Figure 30 : Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 31 : Medtronic: Revenue Share, by Country/Region, FY 2023
Figure 32 : Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 33 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2023
Figure 34 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2023

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Description

Table of Contents

List of Tables

Report Scope

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Market Segmentation Analysis

Chapter 5 Emerging Trends and Technologies

Chapter 6 ESG Developments

Chapter 7 Competitive Landscape

Chapter 8 Appendix

List of Tables

List of Figures